Future of Mosaic
CATEGORIES
- Asset Performance
- Innovation assets and pipeline
- Disruption vulnerability
- Company headlines
- Company’s future prospects
DATA ACCESS
The Mosaic Company is based in Plymouth, Minnesota, a Minneapolis suburb. Mosaic mines two essential crop nutrients—potash and phosphate —and manufactures specialty products MicroEssentials, Pegasus and K-Mag. It is the biggest American manufacturer of potash and phosphate fertilizer.
Innovation assets and Pipeline
All company data collected from its 2015 annual report and other public sources. The accuracy of this data and the conclusions derived from them depend on this publicly accessible data. If a data point listed above is discovered to be inaccurate, Quantumrun will make the necessary corrections to this live page.
DISRUPTION VULNERABILITY
Belonging to the chemicals sector means this company will be affected directly and indirectly by a number of disruptive opportunities and challenges over the coming decades. While described in detail within Quantumrun’s special reports, these disruptive trends can be summarized along the following broad points:
*First off, artificial intelligence (AI) systems will discover new thousands of new compounds faster than humans that can, compounds that can be applied to everything from creating new makeup to cleaning agents to more effective medicines.
*This automated process of chemical compound discovery will accelerate once AI systems are integrated with mature quantum computers by the late 2020s, allowing these AI systems will compute ever more massive amounts of data.
*As the Silent and Boomer generations enter deep into their senior years by the late 2020s, this combined demographic (30-40 per cent of the global population) will represent a significant financial strain on the health systems of developed nations. This crisis will encourage these nations to fast-track the testing and approval process for new drugs that may improve the overall physical and mental health of patients so that they can lead more independent lives outside of the health care system. The chemical industry will partner with the pharmaceutical industry to address this market need.